Gravitate Health FHIR Implementation Guide
0.1.0 - CI Build

Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/gravitate-health/ and changes regularly. See the Directory of published versions

Example Composition: Composition for Biktarvy 50 mg/200 mg/25 mg film-coated tablets Package Leaflet

Generated Narrative: Composition

Resource Composition "composition-proc-es-1846d2b12fecbbb0310cd8c196c98f82" (Language "es")

Profile: Composition (ePI)

HtmlElementLink

url

elementClass

value: indication

url

concept

value: HIV-infection/AIDS (#B90)

HtmlElementLink

url

elementClass

value: pregnancyCategory

url

concept

value: Pregnancy (#W78)

HtmlElementLink

url

elementClass

value: breastfeedingCategory

url

concept

value: Normal breast feeding (finding) (SNOMED CT#69840006)

HtmlElementLink

url

elementClass

value: liver

url

concept

value: Liver disease, other (#D97)

HtmlElementLink

url

elementClass

value: contra-indication-hypericum

url

concept

value: Hypericum perforatum L. (beta#XK4IUX8MNB)

HtmlElementLink

url

elementClass

value: hepatitisB

url

concept

value: Viral hepatitis type B (disorder) (SNOMED CT#66071002)

identifier: https://spor.ema.europa.eu/rmswi//b22ec2e7263c64ba0d74e2718a1859op

status: final

type: Package Leaflet (#100000155538)

category: processed (Category of EPI#P)

date: 2022-02-16 13:28:17+0000

​author: Organization/mah-715f8a161ed438d0584510e5b4512caa

title: TEST PURPOSES ONLY - Biktarvy 50 mg/200 mg/25 mg film-coated tablets

Attesters

-ModeTime
*Official (Composition Attestation Mode#official)2022-02-16 13:28:17+0000